CareAcross is a community for anyone affected by cancer. It is private, free to join, and full of people who understand

Sign in to CareAcross

If you already have an account at CareAcross, please sign in

Invalid Email or Password

Forgot your password?

Remember me

SIGN UP

CareAcross is a community open to anyone affected by cancer: a private and safe place to share practical tips and personal experiences.
By joining you can also find answers to questions, provided by experienced doctors - and even ask your own question.

A study has shown that paediatric cancer patients who are obese may have improved treatment outcomes if they follow a diet and exercise, as they can improve chemotherapy effectiveness and reduce the risk of late effects.

The US FDA has approved the first gene therapy against certain children and young adult patients with a form of acute lymphoblastic leukemia (ALL). This is a groundbreaking development which may pave the way for more such treatments.

When breast cancer patients 65 or older were asked, they reported being more satisfied with the cosmetic outcomes of less radiation, in the long term. However, this should be balanced with a slightly higher recurrence risk.

Adding pertuzumab to a standard regimen for hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancer improved progression-free survival. These were the recently announced results of a clinical trial.

Improved response to treatment against breast cancer with BRCA mutation

Adding veliparib to carboplatin and paclitaxel chemotherapy improved the overall response rate among patients with locally recurrent or metastatic breast cancer with BRCA1 or BRCA2 mutations. This was achieved without increasing side-effects.